This phase I/II trial studies the side effects and best dose of ABBV-383 and to see how well it works in treating patients with Waldenström macroglobulinemia t…

Recurrent Waldenstrom MacroglobulinemiaRefractory Waldenstrom Macroglobulinemia

~Estimated

~$10 – $6,250

Mayo ClinicNCT07420959

Phase 1

MC220806: Phase I Study Evaluating the Efficacy of CSF1R and TAM Receptor or Inhibition in Hematologic Malignancies With Q702, a Small Molecular Inhibitor

This phase I trial tests the safety, side effects, and best dose of Q702 in treating patients with hematologic malignancies. Q702 is in a class of medications …

Hematopoietic and Lymphatic System NeoplasmHistiocytic SarcomaMalignant Histiocytosis+34 more

~Estimated

~$10 – $6,250

Mayo ClinicNCT06712810